COAGULATION FACTOR XII - ANVISA Registration 81457600021
Access comprehensive regulatory information for COAGULATION FACTOR XII in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81457600021 and manufactured by TCOAG IRELAND LIMITED. The registration is held by STAGO BRASIL COMERCIO, IMPORTAÇÃO E EXPORTAÇÃO DE PRODUTOS DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including ROCHE DIAGNOSTICS GMBH, DIAGNOSTICA STAGO S.A.S., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
81457600021
25351399780201901
22260124000220
Company Information
Dates and Status
Feb 03, 2020
VIGENTE
09/18/2025 19:00:01
COAGULATION FACTOR XI
TrinCLOT Factor XI
TCOAG IRELAND LIMITED
81457600020
Feb 03, 2020
COAGULATION FACTOR XII
Factor FXII
ROCHE DIAGNOSTICS GMBH
10287411639
Oct 13, 2022
COAGULATION FACTOR II
TriniCLOT Fator II
TCOAG IRELAND LIMITED
81457600010
Dec 23, 2019
COAGULATION FACTOR X
TriniCLOT Factor X
TCOAG IRELAND LIMITED
81457600011
Dec 23, 2019
COAGULATION FACTOR VIII
TriniCLOT Factor VIII
TCOAG IRELAND LIMITED
81457600013
Jan 20, 2020